share_log

Results: Texas Instruments Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates

Results: Texas Instruments Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates

结果:德州仪器公司超出预期,共识已更新其估计
Simply Wall St ·  04/27 10:31

Shareholders of Texas Instruments Incorporated (NASDAQ:TXN) will be pleased this week, given that the stock price is up 11% to US$177 following its latest first-quarter results. Revenues were US$3.7b, approximately in line with expectations, although statutory earnings per share (EPS) performed substantially better. EPS of US$1.20 were also better than expected, beating analyst predictions by 12%. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Texas Instruments after the latest results.

德州仪器公司(纳斯达克股票代码:TXN)的股东本周将感到高兴,因为在公布最新的第一季度业绩后,股价上涨了11%,至177美元。尽管法定每股收益(EPS)表现要好得多,但收入为37亿美元,大致符合预期。每股收益为1.20美元,也好于预期,比分析师的预测高出12%。根据结果,分析师更新了他们的盈利模式,很高兴知道他们是否认为公司的前景发生了巨大变化,或者业务是否照旧。读者会很高兴得知我们已经汇总了最新的法定预测,以了解分析师在最新业绩公布后是否改变了对德州仪器的看法。

earnings-and-revenue-growth
NasdaqGS:TXN Earnings and Revenue Growth April 27th 2024
NASDAQGS: TXN 收益和收入增长 2024 年 4 月 27 日

After the latest results, the consensus from Texas Instruments' 30 analysts is for revenues of US$15.7b in 2024, which would reflect a measurable 6.3% decline in revenue compared to the last year of performance. Statutory earnings per share are expected to crater 21% to US$5.13 in the same period. In the lead-up to this report, the analysts had been modelling revenues of US$15.6b and earnings per share (EPS) of US$5.03 in 2024. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

最新业绩公布后,德州仪器的30位分析师一致认为,2024年的收入为157亿美元,这将反映出与去年业绩相比,收入将显著下降6.3%。预计同期法定每股收益将下降21%,至5.13美元。在本报告发布之前,分析师一直在模拟2024年的收入为156亿美元,每股收益(EPS)为5.03美元。鉴于他们的估计没有重大变化,共识分析师似乎没有在这些结果中看到任何会改变他们对业务看法的内容。

It will come as no surprise then, to learn that the consensus price target is largely unchanged at US$176. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Texas Instruments, with the most bullish analyst valuing it at US$225 and the most bearish at US$115 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

因此,得知共识目标股价基本保持不变为176美元也就不足为奇了。研究分析师的估计范围,评估异常值与平均值的差异程度也可能很有启发性。对德州仪器的看法有所不同,最看涨的分析师将其估值为225美元,最看跌的为每股115美元。注意到分析师目标股价的巨大差距了吗?对我们来说,这意味着基础业务存在相当广泛的可能情景。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would highlight that revenue is expected to reverse, with a forecast 8.3% annualised decline to the end of 2024. That is a notable change from historical growth of 6.3% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 17% per year. It's pretty clear that Texas Instruments' revenues are expected to perform substantially worse than the wider industry.

从现在的大局来看,我们可以理解这些预测的方法之一是看看它们如何与过去的业绩和行业增长预期相比较。我们要强调的是,收入预计将逆转,预计到2024年底年化下降8.3%。与过去五年6.3%的历史增长相比,这是一个显著的变化。相比之下,我们的数据表明,总体而言,同一行业的其他公司的收入预计每年将增长17%。很明显,德州仪器的收入预计将大大低于整个行业。

The Bottom Line

底线

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Texas Instruments' revenue is expected to perform worse than the wider industry. The consensus price target held steady at US$176, with the latest estimates not enough to have an impact on their price targets.

要了解的最重要的一点是,市场情绪没有重大变化,分析师再次确认该业务的表现符合他们先前的每股收益预期。幸运的是,分析师还重申了他们的收入预期,表明收入符合预期。尽管我们的数据确实表明,德州仪器的收入预计将比整个行业的表现差。共识目标股价稳定在176美元,最新估计不足以对其目标价格产生影响。

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Texas Instruments going out to 2026, and you can see them free on our platform here.

根据这种思路,我们认为该业务的长期前景比明年的收益重要得多。我们对德州仪器到2026年的预测做出了预测,你可以在我们的平台上免费查看。

However, before you get too enthused, we've discovered 2 warning signs for Texas Instruments (1 can't be ignored!) that you should be aware of.

但是,在你变得太热情之前,我们已经发现了德州仪器的 2 个警告标志(1 个不容忽视!)你应该注意的。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发